The Food and Drug Administration awarded the drug’s sponsor, biotech company Revolution Medicines, a new and unconventional ...

Arena launched with $500 million in early 2024 to fund basic biological research, from which it planned to spin out dedicated ...

Discover how Novo Nordisk's pipeline is being restructured to refocus its efforts on high-growth areas like diabetes and ...

Harmony Biosciences has paused a mid-stage trial of ZYN002 in 22q11.2 deletion syndrome after the THC-free cannabinoid drug ...

With $185 million in series A funding and an army of experienced leaders in its ranks, Braveheart Bio is setting off to joust ...

Lipid-based nanoparticles are pivotal in modern medicine, improving drug delivery and mRNA therapies through innovative ...

Biohaven was seeking approval for its drug Vyglxia in the treatment of Spinocerebellar ataxia. ・The company is in the process ...

Contract drug developer Charles River Laboratories on Wednesday raised its annual profit forecast after posting strong third-quarter results, helped by stabilized demand for its drug discovery and ...

Only current shareholders are eligible to attend. No recording using any devices will be permitted. Any reporters, journalists, or writers must identify themselves with their affiliation at the ...

Eli Lilly is doubling down on its partnership with Chinese tech outfit XtalPi, striking a new antibody development pact that ...

Wholesale prices are in the gutter across much of Europe, forcing drug smugglers to try to manipulate the market. OCCRP ...